SAMBO, MARGHERITA
 Distribuzione geografica
Continente #
NA - Nord America 1.560
AS - Asia 1.546
EU - Europa 1.348
SA - Sud America 311
AF - Africa 89
OC - Oceania 2
Totale 4.856
Nazione #
US - Stati Uniti d'America 1.492
IT - Italia 634
SG - Singapore 446
CN - Cina 428
RU - Federazione Russa 388
BR - Brasile 255
VN - Vietnam 181
KR - Corea 152
HK - Hong Kong 129
DE - Germania 63
BD - Bangladesh 59
IN - India 57
ZA - Sudafrica 49
GB - Regno Unito 47
FI - Finlandia 45
FR - Francia 44
CA - Canada 34
IE - Irlanda 26
AR - Argentina 21
MX - Messico 21
AT - Austria 16
ES - Italia 14
NL - Olanda 13
SE - Svezia 12
IQ - Iraq 11
KE - Kenya 10
SA - Arabia Saudita 10
JP - Giappone 9
EG - Egitto 8
ID - Indonesia 8
CL - Cile 7
EC - Ecuador 7
LT - Lituania 7
MA - Marocco 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
JO - Giordania 6
PK - Pakistan 6
PY - Paraguay 6
TR - Turchia 6
BE - Belgio 5
UA - Ucraina 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
HR - Croazia 4
IR - Iran 4
PE - Perù 4
VE - Venezuela 4
CH - Svizzera 3
LU - Lussemburgo 3
MY - Malesia 3
NG - Nigeria 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RO - Romania 1
SN - Senegal 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.856
Città #
Dallas 465
Singapore 282
Milan 270
Hefei 212
San Jose 164
Seoul 152
Santa Clara 143
Hong Kong 126
Moscow 119
Council Bluffs 94
Ashburn 73
Ho Chi Minh City 69
Beijing 64
Los Angeles 64
Rome 64
The Dalles 52
Florence 49
Johannesburg 43
Hanoi 41
Bengaluru 32
Lauterbourg 32
New York 31
Helsinki 26
São Paulo 26
Dublin 25
Buffalo 20
Munich 20
Siena 20
Redondo Beach 18
Lappeenranta 15
Nuremberg 15
Chicago 13
Frankfurt am Main 13
Columbus 11
Orem 11
Messina 10
Mexico City 10
Toronto 10
Bologna 9
Chennai 9
Da Nang 9
Figino 9
Montreal 9
Seattle 9
Atlanta 8
Brooklyn 8
Chandler 8
Curitiba 8
Lucca 8
Naples 8
Turin 8
Vienna 8
Tokyo 7
Amman 6
Boston 6
Brasília 6
Denver 6
Guangzhou 6
Houston 6
Hải Dương 6
Poplar 6
Porto Alegre 6
Rio de Janeiro 6
Varese 6
Brussels 5
Cairo 5
Genoa 5
London 5
Manchester 5
Ninh Bình 5
Shanghai 5
St Louis 5
Stockholm 5
Tashkent 5
Zarautz 5
Baku 4
Bari 4
Bắc Ninh 4
Calgary 4
Cape Town 4
Charlotte 4
Chengdu 4
Cúcuta 4
Dhaka 4
Haiphong 4
Jakarta 4
João Pessoa 4
Lograto 4
Ningbo 4
Portsmouth 4
Querétaro 4
Riyadh 4
Salt Lake City 4
Tampa 4
Tehran 4
Trieste 4
Turku 4
Venice 4
Warsaw 4
Zagreb 4
Totale 3.250
Nome #
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 308
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 222
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 194
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 184
Discordant liver fibrosis predictors in virologically suppressed people living with hiv without hepatitis virus infection 184
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 166
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 166
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 158
An eight-year experience of Nocardia infection in Italy: does immunosuppression matter? 144
Immunity to SARS-CoV-2 up to 15 months after infection 142
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 136
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 136
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 136
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study 129
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 124
Early remdesivir to prevent severe COVID-19 in recipients of solid organ transplant: a real-life study from Northern Italy 121
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count 120
Is a radiological score needed to define the severity of Nontuberculous mycobacteria lung disease? 120
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 119
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 118
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 112
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 111
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 104
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE) 104
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 100
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 98
Circulating endothelial cells in COVID-19 97
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department 95
Mortality due to COVID-19 during the pandemic: A comparison of first, second and third SMAtteo COvid19 REgistry (SMACORE) 94
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit 94
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay 92
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection 92
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 88
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 88
The infection risk after transjugular intrahepatic portosystemic shunt: A multiple competing risk analysis from a tertiary care center 87
SARS Cov-2 infection in a renal-transplanted patient: A case report 84
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 77
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey 68
Cefiderocol therapy among immunocompromised adult patients: a descriptive analysis from a prospective, multicentre cohort study 62
Pharmacokinetic profile of dolutegravir after transjugular intrahepatic portosystemic shunt placement 59
Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature 37
Machine learning approaches to dissect hybrid and vaccine-induced immunity 28
Multidrug-resistant Gram-negative bacteria in lung transplantation: a narrative review of infectious complications and current management 13
Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort 1
Totale 5.012
Categoria #
all - tutte 12.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 0 0 0 0 0 9 5
2022/202327 2 4 3 8 0 5 1 1 3 0 0 0
2023/202447 1 0 6 7 2 12 11 1 2 1 0 4
2024/20251.217 5 6 10 7 226 89 138 70 56 52 120 438
2025/20263.522 290 590 383 451 487 100 315 125 89 204 163 325
2026/2027185 185 0 0 0 0 0 0 0 0 0 0 0
Totale 5.012